<DOC>
	<DOCNO>NCT00843388</DOCNO>
	<brief_summary>A double blind , randomize , cross study type 1 diabetic patient . 20 patient , age 18-65 year treat spironolacton ( Hexalacton ( R ) ) 60 day follow 60 day treatment placebo ( opposite ) . Primary aim : albuminuria , expect decrease hexalacton treatment . Secondary aim : ambulatory blood pressure , GFR , plasma-renin , angiotensin , aldosteron .</brief_summary>
	<brief_title>A Crossover Study With Hexalacton Patients With Type 1 Diabetes Microalbuminuria</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>type 1 diabetes age 1880 year microalbuminuria blood pressure &gt; 160/100 mmHg persistent macroalbuminuria pregnancy risc PPotassium &gt; 5.7 mmol/l Eplerone treatment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>January 2009</verification_date>
</DOC>